Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause

Neither treatment induced deleterious effects in the short term on variables related to cardiovascular risk in early postmenopausal women.